Skip to main content

Bone and Joint Infection clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • A Study of Afabicin in the Treatment of Bone or Joint Infection Due to Staph

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    This is an open-label study to assess the safety and tolerability of Afabicin in the treatment of participants with bone or joint infection due to Staphylococcus aureus [both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)] and/or coagulase-negative staphylococci (CoNS) and to compare it to standard of care (SOC).

    Sacramento, California and other locations

Last updated: